Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026 Research and Development Curie.Bio, Secarna Pharmaceuticals, partnership

Secarna Pharmaceuticals has announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio. The collaboration, first announced …
News

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026 Research and Development Siemens Healthineers

Siemens Healthineers has opened a new Centre of Excellence for Immunoassay Instrument Research & Development in Swords, Ireland. Over 10m …
News

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026 Research and Development Eylea HD, Opthalmology, Regeneron

Regeneron has presented data for Eylea HD (aflibercept) 8mg injection for retinal disease. The data was presented as part of …
News

New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone

February 16, 2026 Research and Development Cardiology, Carvolix

Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic implants, has completed the acquisition …
News

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026 Research and Development Cardiology, Rhythm AI, atrial fibrillation

Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …
News

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026 Research and Development Infinitopes, Oncology

Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …
News

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026 Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …
News

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026 Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …
News

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026 Research and Development Oncology, QV Bioelectronics, glioblastoma

QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …
News

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026 Research and Development HonorHealth Research Institute, Neurology, ischemic stroke

HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has …
News

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026 Medical Communications, Research and Development Biotechnology, IVF, assisted reproductive technology, fertility therapeutics, infertility

By Dr Jordan Abdi Over the past two decades, demand for IVF has risen sharply as parenthood is increasingly delayed …
Feature

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026 Research and Development Barts Health NHS Trust, H.I.G. Realty, health innovation

Barts Health NHS Trust and H.I.G. Realty have announced a collaboration to launch an applied healthcare innovation building in the …
News

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026 Research and Development Diabetes, Ondibta, Sandoz

Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …
News

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026 Research and Development Complement Therapeutics, FDA, Opthalmology, geographic atrophy

Complement Therapeutics has announced that CTx001, its gene therapy treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), …
News

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026 Research and Development Iktos, Oncology, Pierre Fabre Laboratories

Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026